Eupraxia Pharmaceuticals (EPRX) Tax Provisions (2024 - 2026)
Eupraxia Pharmaceuticals' (EPRX) quarterly Tax Provisions came in at -$13905.0 in Q1 2026, down 397.67% year-on-year from $4671.2 in Q1 2025, and down 149.15% on a QoQ basis from -$5581.0 in Q2 2025.
Eupraxia Pharmaceuticals (EPRX) Tax Provisions (2024 - 2026) Analysis & Trends
Eupraxia Pharmaceuticals (EPRX) has 3 years of Tax Provisions data on file, last reported at -$13905.0 in Q1 2026.
- On a quarterly basis, Tax Provisions fell 397.67% year-over-year to -$13905.0 in Q1 2026; TTM through Mar 2026 was -$17280.0, a N/A change from a year earlier, with the FY2025 full-year figure at $19091.0, up 958.26% from the prior year.
- Tax Provisions for Q1 2026 stood at -$13905.0, down from -$5581.0 in the prior quarter.
- Over the last five years, Tax Provisions for EPRX reached as high as $5000.0 in Q2 2024 and fell as low as -$13905.0 in Q1 2026.
- Historically, Tax Provisions has averaged -$4456.0 across 3 years, with a median of -$5000.0 in 2024.
- Across the five-year window, Tax Provisions surged 44.12% in 2025 and plunged 397.67% in 2026, its largest moves.
- Year by year, Tax Provisions stood at $5000.0 in 2024, then sank by 211.62% to -$5581.0 in 2025, then slumped by 149.15% to -$13905.0 in 2026.
- Per Business Quant data, the three most recent Tax Provisions figures were -$13905.0 in Q1 2026, -$5581.0 in Q2 2025, and -$2794.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 125,146.46 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -859,000.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 31.86 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 221.50 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | -60.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Eupraxia Pharmaceuticals | 329.50 Mn | 329.50 Mn | - | -13,905.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -13,905.00 |
| Jun 30, 2025 | -5,581.00 |
| Mar 31, 2025 | -2,794.00 |
| Jun 30, 2024 | 5,000.00 |
| Mar 31, 2024 | -5,000.00 |